Non-specific Effects of a Modified Measles Vaccination Schedule to Prevent Allergy and Unrelated Infection in Children

Study acronym: NEMAU
StatusRecruiting
PhasePhase 4
Started

Record status This record was last updated May 29, 2024 (before its estimated April 2026 completion). Its status may not reflect the trial's current state.

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

  1. Re-verified, no change to tracked fieldsv3
  2. Trial status: Not Yet Recruiting to Recruitingv2 Show 4 more changesShow less
    • Primary completion date: Apr 2025 to Apr 2026
    • Study completion date: Dec 2025 to Dec 2026
    • Start date changed from estimate of Mar 2023 to Mar 17, 2023
    • Site details revised
  3. Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
The goal of this clinical trial is to evaluate the off-target/non-specific effects of the measles-mumps-rubella (MMR) vaccine in children.
Trial Details
NCT Number NCT05758532
Lead Sponsor Laure Pittet, MD-PhD
Conditions
(from sponsor)		 Respiratory Tract Infections, Infections, Allergy, Eczema
Related terms Eczema, Hypersensitivity, Infections, Respiratory Tract Infections
Enrollment 500 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov